-
Mashup Score: 0PSMA-Based Imaging and Theranostics: A Summary of Current Paradigm Shifts and a Look to the Future - 10 month(s) ago
The panel discusses the possibility of PSMA-PET becoming the standard-of-care imaging modality for prostate cancer, which may obviate the need for conventional imaging and bone scans, and then touches on the increasing availability of PSMA-targeted radiotherapies.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2
“The Inflation Reduction Act could impact the livelihoods of a lot of patients by reducing their annual out-of-pocket costs,” says Brian Cortese.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
.@BrianCortese_ highlights policy and practice implications of the Inflation Reduction Act in urology. #urology #urologist Watch now: https://t.co/aSBtBMjGXm
-
-
Mashup Score: 0
Analysis shows MRI is comparable to post-surgery pathologic staging for assessing risk of biochemical recurrence.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Study suggests pre-prostatectomy MRI can identify patients with high recurrence risk. #urology #urologist #pcsm #prostatecancer Read more: https://t.co/SGg7AsujLf
-
-
Mashup Score: 1
“The beauty is, now we can deliver a cisplatin-based chemotherapeutic orally, which is usually never done. And by targeting the prostate, we can reduce kidney and liver toxicity and the risk of peripheral neuropathy,” says Shanta Dhar, PhD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Orally administered cisplatin prodrug Platin-L shows initial promise in treatment-resistant prostate cancer. #urology #urologist #pcsm #prostatecancer Read more: https://t.co/qE2uMuNDpk
-
-
Mashup Score: 0Dr. North on burnout among women urologists - 10 month(s) ago
“In 2021, we were finally able to demonstrate a statistically significant difference in burnout between men and women in urology with women having much higher burnout rates,” says Amanda C. North, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. Amanda North discusses burnout among women urologists. #urology #urologist @anorth21 @MontefioreUro @MontefioreNYC Watch now: https://t.co/nvjxI0rVky
-
-
Mashup Score: 0Investigators seek men of African ancestry for study exploring prostate cancer risk factors - 10 month(s) ago
The prospective cohort study seeks to enroll 200 patients from the South Florida region and 1800 patients from international sites.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Investigators are seeking men of African ancestry who have received a diagnosis of prostate cancer to enroll in the African Cancer Genome Registry. #urology #urologist #pcsm #prostatecancer Read more: https://t.co/hfwCN80wv6
-
-
Mashup Score: 0Is a medical scribe right for your practice? - 10 month(s) ago
“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Is a medical scribe right for your practice? #urology #urologist #practicemanagement Expert weighs in here: https://t.co/hld0nT3jrk
-
-
Mashup Score: 0
Urologists and other medical professionals can begin using the code on January 1, 2024 to facilitate the reimbursement of Li-ESWT involving the corpus cavernosum.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
CPT code X170T issued for low-intensity extracorporeal shock wave therapy. #urology #urologist Read more: https://t.co/HOo4wGQGfD
-
-
Mashup Score: 0Dr. Brittany Szymaniak discusses BRCA+ men’s clinic - 10 month(s) ago
“My predominant role as a genetic counselor is really to serve our patient population and help support our providers,” says Brittany M. Szymaniak, PhD, CGC.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. Brittany Szymaniak discusses the EDGe BRCA+ men’s clinic. #urology #urologist @NM_Urology Watch now: https://t.co/U7KCfvcRA4
-
-
Mashup Score: 1Inflation Reduction Act may lower patients' Medicare costs for prostate cancer treatment - 10 month(s) ago
“Within the Inflation Reduction Act, there is a provision that will cap the out-of-pocket contribution for Medicare beneficiaries, dropping to $3250 in 2024, as well as $2,000 in 2025,” says Brian Cortese.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
.@BrianCortese_ discusses how the Inflation Reduction Act may lower out-of-pocket Medicare costs for prostate cancer treatment. #urology #urologist #pcsm #prostatecancer Watch now: https://t.co/uxvu3Mwyqb
-
Experts provide a summary of current paradigm shifts and a look to the future for PSMA-based imaging and theranostics. #urology #urologist #pcsm #prostatecancer @uromc @PhillipKooMD @OUUrology Watch now: https://t.co/ce3qFRGFmR